Missed opportunities with new UK screening test
Parents may miss opportunities to abort handicapped children if a new type of prenatal genetic testing is adopted in the UK, complain researchers in the most recent issue of The Lancet. The UK National Screening Committee recommended last year that new screening programs for Down Syndrome do not have to include karyotyping, a process which analyses a person’s 23 chromosome pairs but takes up to 14 days to produce. Instead it recommends quicker and simpler tests called FISH or PCR.
Dr John Crolla, of Wessex Regional Genetics Laboratory, says that the new policy will result in substantial numbers of liveborn children with hitherto preventable mental or physical handicaps. This represents, he contends, a substantial change in the outcome quality of prenatal testing offered to couples in the UK.
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
A painful debate: shrinking the carbon footprint of anaesthetics
If there is any profession which seems remote from the Sturm und Drang of climate change, it must be anaesthetists....
Some patients recall death experiences after heart attacks
In an article in the journal Resuscitation, some survivors of cardiac arrest have described lucid death experiences that occurred while...
Queensland widower dies after taking assisted suicide drugs ordered by his wife
“Move along, please. Nothing to see here.” This was more or less the reaction of supporters of “voluntary assisted dying”...
Australian first: nurse donates organs after euthanasia
A Victorian woman has become the first Australian to combine death by euthanasia with organ donation. Ballarat nurse Marlene Bevern,...
Canadian study hints at crushing institutional conscience objections to ‘assisted dying’
Supporters of “voluntary assisted dying” fought hard to achieve legalisation in various jurisdictions around the world. After legalisation, however, battles...
Hope, hype and xenotransplantation
On January 7, 2022 David Bennett, a 57-year-old with terminal heart disease, made history as the first person to receive...